Li, Zhijie <br/><br/>
Inactivation of glycogen synthase kinase-3beta contributes to brain-derived neutrophic factor/TrkB-induced resistance to chemotherapy in neuroblastoma cells.  [electronic resource] 

 -  Molecular cancer therapeutics  Dec 2007 
 - 3113-21 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1535-7163 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-07-0133  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Brain-Derived Neurotrophic Factor--physiology<br/>Cell Line, Tumor<br/>Cisplatin--therapeutic use<br/>Drug Resistance, Neoplasm<br/>Etoposide--pharmacology<br/>Flow Cytometry<br/>Glycogen Synthase Kinase 3--antagonists & inhibitors<br/>Glycogen Synthase Kinase 3 beta<br/>Humans<br/>Membrane Potentials--drug effects<br/>Neuroblastoma--drug therapy<br/>Phosphorylation<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>RNA, Small Interfering<br/>Receptor, trkB--physiology